Clinical Trials Browser

Phase 2/3 × INDUSTRY × ublituximab × Clear all

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02793583 2022-07-21

UNITY-NHL

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Clinical Trials

ULTRA-V

UNITY-NHL